Gilead adds investigational HIV vaccine to its portfolio from Spanish biotech
Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.
Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.
What's Your Reaction?
